SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Daniel Goncharoff who wrote (31)3/13/1997 6:46:00 AM
From: Michael H. Dragon   of 298
 
Checking for insider sales shows no insider sales this year.Also the
30 patients or so involved with the phase 2 trials are still supposebly on Myloral and have been now for about 6 years.I've seen
precipitous price drops in Biotechs in the past in anticipation of
clinical trial results and inevitably the stock bounces back prior to
release of trials.I don't understand the selling because even if the trials are negative I beleive the stock price will go up some time prior to the release of the phase 3 trials.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News